Efficacy of vaccination against severe COVID-19 in relation to Delta variant and time since second dose: the REACT-SCOT case-control study
View ORCID ProfilePaul M McKeigue, View ORCID ProfileDavid A McAllister, Sharon J Hutchinson, Chris Robertson, Diane Stockton, View ORCID ProfileHelen M Colhoun, for the PHS COVID-19 Epidemiology and Research Cell
doi: https://doi.org/10.1101/2021.09.12.21263448
Paul M McKeigue
1Usher Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Teviot Place, Edinburgh EH8 9AG, Scotland
6Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
David A McAllister
2Institute of Health and Wellbeing, University of Glasgow, 1 Lilybank Gardens, Glasgow G12 8RZ
6Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
Sharon J Hutchinson
3School of Health and Life Sciences, Glasgow Caledonian University. SH - Professor of Epidemiology and Population Health
6Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
Chris Robertson
4Department of Mathematics and Statistics, University of Strathclyde, 16 Richmond Street, Glasgow G1 1XQ
6Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
Diane Stockton
6Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
Helen M Colhoun
5Institute of Genetics and Cancer, College of Medicine and Veterinary Medicine, University of Edinburgh, Western General Hospital Campus, Crewe Road, Edinburgh EH4 2XUC, Scotland
6Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
6Public Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow G2 6QE
Data Availability
The component datasets used here are available via the Public Benefits and Privacy Panel for Health and Social Care at https://www.informationgovernance.scot.nhs.uk/pbpphsc/ for researchers who meet the criteria for access to confidential data. All source code used for derivation of variables, statistical analysis and generation of this manuscript is available on https://github.com/pmckeigue/covid-scotland_public.
Posted September 15, 2021.
Efficacy of vaccination against severe COVID-19 in relation to Delta variant and time since second dose: the REACT-SCOT case-control study
Paul M McKeigue, David A McAllister, Sharon J Hutchinson, Chris Robertson, Diane Stockton, Helen M Colhoun, for the PHS COVID-19 Epidemiology and Research Cell
medRxiv 2021.09.12.21263448; doi: https://doi.org/10.1101/2021.09.12.21263448
Efficacy of vaccination against severe COVID-19 in relation to Delta variant and time since second dose: the REACT-SCOT case-control study
Paul M McKeigue, David A McAllister, Sharon J Hutchinson, Chris Robertson, Diane Stockton, Helen M Colhoun, for the PHS COVID-19 Epidemiology and Research Cell
medRxiv 2021.09.12.21263448; doi: https://doi.org/10.1101/2021.09.12.21263448
Subject Area
Subject Areas
- Addiction Medicine (322)
- Allergy and Immunology (625)
- Anesthesia (162)
- Cardiovascular Medicine (2337)
- Dermatology (205)
- Emergency Medicine (374)
- Epidemiology (11705)
- Forensic Medicine (10)
- Gastroenterology (693)
- Genetic and Genomic Medicine (3689)
- Geriatric Medicine (345)
- Health Economics (632)
- Health Informatics (2367)
- Health Policy (926)
- Hematology (340)
- HIV/AIDS (773)
- Medical Education (364)
- Medical Ethics (104)
- Nephrology (396)
- Neurology (3452)
- Nursing (195)
- Nutrition (520)
- Oncology (1802)
- Ophthalmology (533)
- Orthopedics (218)
- Otolaryngology (286)
- Pain Medicine (231)
- Palliative Medicine (66)
- Pathology (444)
- Pediatrics (1021)
- Primary Care Research (415)
- Public and Global Health (6092)
- Radiology and Imaging (1257)
- Respiratory Medicine (821)
- Rheumatology (375)
- Sports Medicine (320)
- Surgery (396)
- Toxicology (50)
- Transplantation (171)
- Urology (144)